ATE362528T1 - Fusionsproteine bestehend aus proteingerüst und bibliotheken von zufälligen peptiden - Google Patents

Fusionsproteine bestehend aus proteingerüst und bibliotheken von zufälligen peptiden

Info

Publication number
ATE362528T1
ATE362528T1 AT99957466T AT99957466T ATE362528T1 AT E362528 T1 ATE362528 T1 AT E362528T1 AT 99957466 T AT99957466 T AT 99957466T AT 99957466 T AT99957466 T AT 99957466T AT E362528 T1 ATE362528 T1 AT E362528T1
Authority
AT
Austria
Prior art keywords
peptides
random
terminal
increase
libraries
Prior art date
Application number
AT99957466T
Other languages
English (en)
Inventor
David Anderson
Jakob Bogenberger
Beau Peelle
Original Assignee
Rigel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rigel Pharmaceuticals Inc filed Critical Rigel Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE362528T1 publication Critical patent/ATE362528T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1044—Preparation or screening of libraries displayed on scaffold proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99957466T 1998-10-08 1999-10-08 Fusionsproteine bestehend aus proteingerüst und bibliotheken von zufälligen peptiden ATE362528T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/169,015 US6180343B1 (en) 1998-10-08 1998-10-08 Green fluorescent protein fusions with random peptides

Publications (1)

Publication Number Publication Date
ATE362528T1 true ATE362528T1 (de) 2007-06-15

Family

ID=22613927

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99957466T ATE362528T1 (de) 1998-10-08 1999-10-08 Fusionsproteine bestehend aus proteingerüst und bibliotheken von zufälligen peptiden

Country Status (8)

Country Link
US (5) US6180343B1 (de)
EP (1) EP1119617B1 (de)
JP (1) JP2002526108A (de)
AT (1) ATE362528T1 (de)
AU (1) AU768126B2 (de)
CA (1) CA2345215A1 (de)
DE (1) DE69936103T2 (de)
WO (1) WO2000020574A2 (de)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020110834A1 (en) * 1994-11-04 2002-08-15 Benkovic Stephen J. Fluorescent assay for proteolysis
US6969584B2 (en) * 1997-06-12 2005-11-29 Rigel Pharmaceuticals, Inc. Combinatorial enzymatic complexes
US6709814B1 (en) * 1998-04-02 2004-03-23 Rigel Pharmaceuticals, Inc. Peptides causing formation of compact structures
US7090976B2 (en) 1999-11-10 2006-08-15 Rigel Pharmaceuticals, Inc. Methods and compositions comprising Renilla GFP
US6180343B1 (en) * 1998-10-08 2001-01-30 Rigel Pharmaceuticals, Inc. Green fluorescent protein fusions with random peptides
US6936421B2 (en) * 1998-10-08 2005-08-30 Rigel Pharmaceuticals, Inc. Structurally biased random peptide libraries based on different scaffolds
WO2000022112A1 (en) * 1998-10-13 2000-04-20 The University Of Georgia Research Foundation, Inc. Stabilized bioactive peptides and methods of identification, synthesis and use
US20030190740A1 (en) * 1998-10-13 2003-10-09 The University Of Georgia Research Foundation, Inc Stabilized bioactive peptides and methods of identification, synthesis, and use
US20030166003A1 (en) * 1999-06-14 2003-09-04 Cochran Andrea G. Structured peptide scaffold for displaying turn libraries on phage
US6673554B1 (en) * 1999-06-14 2004-01-06 Trellie Bioinformatics, Inc. Protein localization assays for toxicity and antidotes thereto
ATE296350T1 (de) * 1999-06-14 2005-06-15 Genentech Inc Strukturiertes peptidgerüst zur ausstellung von drehung-bibliotheken auf phage
WO2001009177A2 (en) * 1999-07-29 2001-02-08 Whitehead Institute For Biomedical Research Affinity fluorescent proteins and uses thereof
AU4183200A (en) * 1999-10-21 2001-04-30 Panorama Research, Inc. A general method for optimizing the expression of heterologous proteins
US7109315B2 (en) * 2000-03-15 2006-09-19 Bruce J. Bryan Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
WO2001075178A2 (en) * 2000-04-04 2001-10-11 Enanta Pharmaceuticals, Inc. Methods for identifying peptide aptamers capable of altering a cell phenotype
BR0109919A (pt) * 2000-04-07 2003-03-11 Univ Leeds Innovations Ltd Proteìna, partìcula, molécula de ácido nucleico, célula hospedeira, processo para produzir uma proteìna, composição farmacêutica, uso de uma proteìna, e, método de vacinação profilática ou terapêutica de um indivìduo
US6780599B2 (en) 2000-05-12 2004-08-24 Yale University Methods of detecting interactions between proteins, peptides or libraries thereof using fusion proteins
US7083945B1 (en) * 2000-10-27 2006-08-01 The Board Of Regents Of The University Of Texas System Isolation of binding proteins with high affinity to ligands
EP2284270A3 (de) * 2000-12-13 2012-07-25 Anaphore, Inc. Verfahren zur Identifizierung und Isolierung von bindenden Polypeptiden aus kombinatorischen Bibliotheken von Proteinen mit der Gerüststruktur von lectinähnlichen Domänen vom C-typ
CA2430953A1 (en) * 2000-12-13 2002-06-20 Borean Pharma A/S Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains
US20030036049A1 (en) * 2001-01-03 2003-02-20 Medis El Ltd. Optical method for testing sensitivity of cells
US20020183937A1 (en) * 2001-02-09 2002-12-05 Stephen Mayo Method for the generation of proteins with new enzymatic function
WO2002068630A1 (en) * 2001-02-22 2002-09-06 Praecis Pharmaceuticals Incorporated Methods for identifying peptides which modulate a biological process
US6914123B2 (en) 2001-04-17 2005-07-05 Genentech, Inc. Hairpin peptides with a novel structural motif and methods relating thereto
AU2002326751A1 (en) 2001-08-13 2003-03-03 Ige Therapeutics, Inc. Immunoglobulin e vaccines and methods of use thereof
FR2830020B1 (fr) * 2001-09-25 2003-12-19 Univ Victor Segalen Bordeaux 2 Acide nucleique pour l'obtention d'un polynucleotide codant une proteine de detection et d'isolement d'un ligand "proie" et applications de cet acide nucleique
US20030134287A1 (en) * 2002-01-16 2003-07-17 Xianqiang Li Method for isolating and characterizing short-lived proteins
AU2003209272A1 (en) * 2002-01-16 2003-09-02 Zyomyx, Inc. Engineered binding proteins
US7056665B2 (en) 2002-01-16 2006-06-06 Panomics, Inc. Screening methods involving the detection of short-lived proteins
EP1470224B1 (de) * 2002-01-23 2011-01-12 Mohammed Raafat El-Gewely Molekulare bibliotheken
AU2003223244A1 (en) * 2002-03-11 2003-09-29 The Johns Hopkins University Molecular switches and methods for making and using the same
JP2006506950A (ja) * 2002-04-19 2006-03-02 バイオイメージ・アクティーゼルスカブ ２つの緑色蛍光タンパク質断片およびタンパク質−タンパク質の相互作用を検出するための方法におけるこれらの使用
US20030219723A1 (en) * 2002-05-20 2003-11-27 Lu Henry H. Compositions and methods for screening and identifying anti-HCV agents
CA2492074A1 (en) * 2002-07-10 2004-01-15 Stratagene Humanized renilla reniformis green fluorescent protein as a scaffold
DE60330468D1 (de) 2002-08-21 2010-01-21 Revivicor Inc Schweine ohne jegliche expression funktioneller alpha-1,3-galactosyltransferase
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US7323303B2 (en) * 2003-03-31 2008-01-29 Hong Kong Polytechnic University Modified β-lactamases and uses thereof
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
US7566447B2 (en) 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US20050014932A1 (en) * 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
WO2005047461A2 (en) 2003-08-18 2005-05-26 The Regents Of The University Of California Polypeptide display libraries and methods of making and using thereof
US7897384B2 (en) 2003-09-08 2011-03-01 Ethicon, Inc. Chondrocyte therapeutic delivery system
US8257963B2 (en) 2007-06-01 2012-09-04 Depuy Mitek, Inc. Chondrocyte container and method of use
US7927599B2 (en) * 2003-09-08 2011-04-19 Ethicon, Inc. Chondrocyte therapeutic delivery system
WO2005072392A2 (en) 2004-01-28 2005-08-11 John Hopkins University Methods for making and using molecular switches involving circular permutation
WO2005087793A2 (en) * 2004-02-05 2005-09-22 The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Immunostimulatory compositions and uses thereof
US7745196B1 (en) 2004-03-25 2010-06-29 Rigel Pharmaceuticals, Inc. Methods and compositions for identifying peptide modulators of cell surface receptors
WO2005115433A2 (en) * 2004-05-24 2005-12-08 Rigel Pharmaceuticals, Inc. Methods for cyclizing synthetic polymers
CN101031655A (zh) 2004-07-26 2007-09-05 陶氏环球技术公司 通过株工程改进蛋白表达的方法
AU2005332655A1 (en) * 2004-10-20 2006-12-14 Iogenetics, Llc Biocides
DE602006003695D1 (de) * 2005-01-05 2009-01-02 F Star Biotech Forsch & Entw Synthetische Immunoglobulindomänen mit in Regionen des Moleküls, die sich von den die Komplementarität bestimmenden Bereichen unterscheiden, modifizierten Bindeeigenschaften
US8128952B2 (en) * 2005-01-12 2012-03-06 Clemson University Research Foundation Ligand-mediated controlled drug delivery
EP1924686A4 (de) 2005-08-09 2009-11-11 Revivicor Inc Ctla4-ig exprimierende transgene huftiere und deren verwendung
EP2535346B1 (de) * 2005-08-31 2017-08-02 The Regents of The University of California Zelluläre Peptidsequenzbibliotheken (CLiPS) und Verwendungsverfahren dafür
CN100355950C (zh) * 2005-09-01 2007-12-19 南方医科大学 一种多肽随机文库及其构建方法和从该文库中筛选细胞穿透多肽的方法
JP2007197435A (ja) * 2005-12-28 2007-08-09 Canon Inc 金結合性タンパク質
AT503474A1 (de) * 2006-03-29 2007-10-15 Univ Wien Bodenkultur Peptidbibliothek
KR100783670B1 (ko) 2006-05-22 2007-12-07 한국표준과학연구원 도메인 단백질을 이용한 생리활성물질의 검색 방법
AT503889B1 (de) 2006-07-05 2011-12-15 Star Biotechnologische Forschungs Und Entwicklungsges M B H F Multivalente immunglobuline
AT503902B1 (de) * 2006-07-05 2008-06-15 F Star Biotech Forsch & Entw Verfahren zur manipulation von immunglobulinen
US7798090B2 (en) * 2007-01-05 2010-09-21 Thomas Angell Hatfield Rescue and locational determination equipment
US20100004134A1 (en) * 2007-01-12 2010-01-07 Lawrence Horowitz Combinatorial libraries of conformationally constrained polypeptide sequences
WO2008128144A2 (en) * 2007-04-15 2008-10-23 Shuang Zhang Monoclonal antibody selecting system, and making and using thereof
WO2008134461A2 (en) 2007-04-27 2008-11-06 Dow Global Technologies, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
EP2000952B1 (de) 2007-05-31 2013-06-12 Industrial Technology Research Institute Verfahren und Vorrichtung zur Raucherkennung
ES2627223T3 (es) 2007-06-26 2017-07-27 F-Star Biotechnologische Forschungs- Und Entwicklungsges.M.B.H Presentación de agentes de unión
US8293685B2 (en) 2007-07-26 2012-10-23 The Regents Of The University Of California Methods for enhancing bacterial cell display of proteins and peptides
US7943733B2 (en) * 2007-12-20 2011-05-17 University Of Southern California Spacers to increase the expression of recombinant fusion proteins
EP2113255A1 (de) 2008-05-02 2009-11-04 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Zytotoxisches Immunglobulin
EP3543256A1 (de) 2009-01-12 2019-09-25 Cytomx Therapeutics Inc. Modifizierte antikörperzusammensetzungen, verfahren zur herstellung und verwendung davon
CA2753294A1 (en) 2009-02-23 2010-08-26 Cytomx Therapeutics, Inc. Proproteins and methods of use thereof
US20100305002A1 (en) * 2009-04-27 2010-12-02 Roswell Park Cancer Institute Reagents and Methods for Producing Bioactive Secreted Peptides
EP2424971A4 (de) * 2009-05-01 2013-07-31 Univ Utah Res Found Verfahren und zusammensetzungen zur messung von hochaffinen interaktionen mit kinetischer bildgebung einer einzelmolekülinteraktion (kismi)
WO2011071279A2 (ko) * 2009-12-11 2011-06-16 광주과학기술원 Bpb-기반 카르고 운반 시스템
WO2011071280A2 (ko) * 2009-12-11 2011-06-16 광주과학기술원 세포내 타겟 결합용 바이포달 펩타이드 바인더
JP6034696B2 (ja) 2010-02-12 2016-11-30 オンコメッド ファーマシューティカルズ インコーポレイテッド ポリペプチド発現細胞の同定及び単離の方法
KR101294982B1 (ko) 2011-12-09 2013-08-08 경북대학교 산학협력단 단백질 골격모듈을 포함하는 융합 폴리펩타이드 및 이를 이용한 목적 단백질에 특이적인 펩타이드 라이브러리 스크리닝 방법
US9200291B2 (en) 2012-12-19 2015-12-01 Helge Zieler Compositions and methods for creating altered and improved cells and organisms
US10077441B2 (en) 2014-01-09 2018-09-18 Primordial Genetics Inc. Methods and compositions for creating altered and improved cells and organisms
EP3666897A4 (de) * 2017-07-31 2020-11-04 The University Of Tokyo Überaus vielseitiges verfahren zur darstellung eines zyklischen peptids auf einer proteinstruktur
CA3111050A1 (en) * 2018-07-31 2020-02-06 The University Of Tokyo Highly versatile method for granting new binding specificity to antibody
JP7202577B2 (ja) * 2018-08-01 2023-01-12 国立大学法人 鹿児島大学 ペプチド融合タンパク質
BR102019017792A2 (pt) 2019-08-27 2021-11-16 Fundação Oswaldo Cruz Receptáculo proteico, método para produção do receptáculo, método de identificação de patógenos ou de diagnóstico de doenças, e, uso do receptáculo
EP4028413A1 (de) 2019-09-10 2022-07-20 Obsidian Therapeutics, Inc. Ca2-il15-fusionsproteine zur abstimmbaren regulierung
CN117092084B (zh) * 2023-10-20 2024-01-12 浙江迪福润丝生物科技有限公司 Wnv蛋白酶抑制剂的筛选方法和抑制效果评价方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5635182A (en) 1994-06-16 1997-06-03 Genetics Institute, Inc. Method of detecting ligand interactions
EP0851874B1 (de) * 1995-09-22 1999-09-15 Novo Nordisk A/S Varianten des grünen fluoreszenzproteins, gfp
JP2000511050A (ja) 1996-05-31 2000-08-29 メディジーン・アクチェンゲゼルシャフト 機能性分子表面の生成、スクリーニング、および展開のための新規の合成タンパク質の構造の鋳型
US5955275A (en) 1997-02-14 1999-09-21 Arcaris, Inc. Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes
US6025485A (en) 1997-02-14 2000-02-15 Arcaris, Inc. Methods and compositions for peptide libraries displayed on light-emitting scaffolds
US6623922B1 (en) 1997-02-14 2003-09-23 Deltagen Proteomics Methods for identifying, characterizing, and evolving cell-type specific CIS regulatory elements
AU765703B2 (en) * 1998-03-27 2003-09-25 Bruce J. Bryan Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
US6180343B1 (en) * 1998-10-08 2001-01-30 Rigel Pharmaceuticals, Inc. Green fluorescent protein fusions with random peptides

Also Published As

Publication number Publication date
EP1119617A2 (de) 2001-08-01
DE69936103T2 (de) 2008-05-15
WO2000020574A9 (en) 2001-06-21
US6596485B2 (en) 2003-07-22
US6548632B1 (en) 2003-04-15
DE69936103D1 (de) 2007-06-28
WO2000020574A3 (en) 2000-09-21
WO2000020574A2 (en) 2000-04-13
AU1516400A (en) 2000-04-26
US20010003650A1 (en) 2001-06-14
EP1119617B1 (de) 2007-05-16
US6180343B1 (en) 2001-01-30
JP2002526108A (ja) 2002-08-20
AU768126B2 (en) 2003-12-04
CA2345215A1 (en) 2000-04-13
US6562617B1 (en) 2003-05-13
US6548249B1 (en) 2003-04-15

Similar Documents

Publication Publication Date Title
ATE362528T1 (de) Fusionsproteine bestehend aus proteingerüst und bibliotheken von zufälligen peptiden
Campos et al. The active site of pepsin is formed in the intermediate conformation dominant at mildly acidic pH
Blout et al. New cotton effects in polypeptides and proteins
DK1266025T3 (da) Protein-scaffolds for antistof-mimetika og andre bindingsproteiner
DE59903410D1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
DE50112802D1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
NZ501767A (en) Cyclic integrin binding peptide with the amino acid sequence RKK
DE60143545D1 (de) Isolierung von bindungsproteinen mit hoher affinität für liganden
ATE397084T1 (de) Lentivirale verpackungskonstrukte
ATE513056T1 (de) Stabilisierte proteine
FI960392A (fi) Immunomääritys kollageenin tai kollageenifragmenttien osoittamiseksi
DE69834643D1 (de) Adipozyten-spezifische protein homologe
Krammer et al. A MIF‐derived cyclopeptide that inhibits MIF binding and atherogenic signaling via the chemokine receptor CXCR2
NO993468L (no) Syntetiske peptid-epitoper fra proteinet fra Pre-M/M fra dengue-virus
IL145689A0 (en) Methods
FR2816410B1 (fr) Necessaire de detection de la proteine esm-1 et procede de detection mettant en oeuvre ledit necessaire
DE69619982D1 (de) Stabilisierte standards und kalibratoren
ATE412745T1 (de) Antiangiogene peptide vom n-terminus von endostatin
ATE402714T1 (de) Stabilisierung von pharmazeutischen epo- formulierungen mit kleinen peptiden
KR930701487A (ko) 식물성 독소 겔로닌의 단백질 구조물
DE602004011686D1 (de) Avidinmutanten
CA2511830A1 (en) Mixture of at least two fusion proteins as well as their production and use
Heal et al. A search within the IL-1 type I receptor reveals a peptide with hydropathic complementarity to the IL-1β trigger loop which binds to IL-1 and inhibits in vitro responses
ATE452650T1 (de) Transferrin-fusionsproteinbibliotheken
Sikorski et al. Selective display of a chemoattractant agonist on cancer cells activates the formyl peptide receptor 1 on immune cells

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties